SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense volatility as market participants debate whether the stock has hit a structural bottom near 12-year lows or if it faces further downside due to ongoing turnaround hurdles and tariff pressures. Investors are closely monitoring significant insider buying activity and potential catalysts like the upcoming World Cup to gauge whether the brand's long-term dominance can overcome current operational struggles.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently trending as retail investors express intense frustration over stagnant stock performance and skepticism regarding CEO Tom Lee's aggressive Ethereum accumulation strategy. The community is actively debating the potential impact of the upcoming CLARITY Act legislation while simultaneously questioning the company's reliance on share dilution and whether the CEO's long-term projections remain credible amid recent price volatility.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors await extended Phase 3 data for its prostate cancer therapy, CAN-2409, to be presented at the upcoming AUA Annual Meeting. The community is focused on the potential for this data to validate the drug's durability and clinical efficacy, with many discussing the likelihood of a premium acquisition by Big Pharma given the stock's low market cap relative to its peak sales potential.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is currently the subject of intense community debate as investors weigh concerns over high debt levels and subscriber losses against the company's aggressive share buyback strategy and deeply discounted valuation. Many are closely tracking the stock's high short interest and potential for a short squeeze, while others are closely monitoring insider buying patterns and the progress of the Cox merger as key catalysts.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is experiencing a surge in investor interest driven by its critical role in AI data center infrastructure and industrial supply chain constraints. The community is actively debating the strength of this rally, with many retail investors holding firm through volatility, anticipating a push toward higher price levels despite ongoing discussions about inflation and Federal Reserve policy.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors debate its long-term value against a backdrop of stagnant price action and upcoming patent cliffs, while some community members highlight its secure dividend as a defensive play. The stock is currently a major focus for active traders monitoring technical support levels and potential reversal signals amid broader sector rotation.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart shares are facing intense selling pressure following a Q1 earnings report that disappointed investors on profitability metrics despite delivering revenue growth. The community remains deeply divided, with some investors pinning their hopes on a potential short squeeze fueled by high short interest and future partnership potential, while others express growing frustration over the stock's persistent underperformance relative to broader market gains.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense volatility and social media discussion following a strategic $100 million capital injection from the Winklevoss Capital Fund, a move many retail investors view as a signal of founder conviction despite ongoing concerns about the company's financial health. Community sentiment is deeply divided, with some traders optimistic about a potential short squeeze fueled by high short interest and crypto sector tailwinds, while others remain skeptical, citing past performance, significant valuation gaps compared to the IPO, and a history of shareholder lawsuits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RXRX 

Morgan Stanley raising it 5.5 from 5 
Well not bad considering the stock price and recent action

John

ryan koubeserian

$RXRX Morgan Stanley Raises Price Target on Recursion Pharmaceuticals to $5.50 From $5, Keeps Equalweight Rating

StockTwits Web

Recursion Pharmaceuticals Inc

john weinacker

StockTwits for iOS

 

Morgan Stanley raising it 5.5 from 5 
Well not bad considering the stock price and recent action